Your Messages Inbox
Your Article Summary
See Latest ArticlesSchering-Plough Receives Clarification of Its Rights for Golimumab
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/18/06
Schering-Plough Corporation announced clarification on its question regarding the expiration date for its rights to market golimumab worldwide, excluding the United States, Japan and certain other Asian markets. As announced in August 2005, Schering-Plough and Centocor, Inc. stated that they were working together to move forward with their collaboration on golimumab and were taking steps to resolve the difference of opinion as to the expiration date
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Article Search
Sponsor